Skip to main content
The BMJ logoLink to The BMJ
letter
. 1990 Nov 3;301(6759):1049–1050. doi: 10.1136/bmj.301.6759.1049-d

Myocardial infarction associated with dextrofenfluramine.

PMCID: PMC1664012  PMID: 2249064

Full text

PDF
1049

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Durnin J. V. Microdiets: love them or leave them? Br Med J (Clin Res Ed) 1987 Jun 20;294(6587):1565–1565. doi: 10.1136/bmj.294.6587.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evrard P., Allaz A. F. Myocardial infarction associated with the use of dextrofenfluramine. BMJ. 1990 Aug 11;301(6747):345–345. doi: 10.1136/bmj.301.6747.345-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Guy-Grand B., Apfelbaum M., Crepaldi G., Gries A., Lefebvre P., Turner P. International trial of long-term dexfenfluramine in obesity. Lancet. 1989 Nov 11;2(8672):1142–1145. doi: 10.1016/s0140-6736(89)91499-2. [DOI] [PubMed] [Google Scholar]
  4. Shapiro S., Slone D., Rosenberg L., Kaufman D. W., Stolley P. D., Miettinen O. S. Oral-contraceptive use in relation to myocardial infarction. Lancet. 1979 Apr 7;1(8119):743–747. doi: 10.1016/s0140-6736(79)91205-4. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES